These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19608023)

  • 21. The association of plasma cysteine and gamma-glutamyltransferase with BMI and obesity.
    Elshorbagy AK; Refsum H; Smith AD; Graham IM
    Obesity (Silver Spring); 2009 Jul; 17(7):1435-40. PubMed ID: 19214177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between soluble CD40 ligand and gamma-glutamyltransferase concentrations in non-drinking, young Type 1 diabetic individuals.
    Zoppini G; Targher G; Trombetta M; Lippi G; Muggeo M
    Diabet Med; 2008 Nov; 25(11):1283-8. PubMed ID: 19046217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids.
    Thamer C; Tschritter O; Haap M; Shirkavand F; Machann J; Fritsche A; Schick F; Häring H; Stumvoll M
    Horm Metab Res; 2005 Apr; 37(4):246-51. PubMed ID: 15952086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased serum gamma-glutamyltransferase activity in patients with metabolic syndrome.
    Bozbaş H; Yıldırır A; Karaçağlar E; Demir O; Ulus T; Eroğlu S; Aydınalp A; Ozin B; Müderrisoğlu H
    Turk Kardiyol Dern Ars; 2011 Mar; 39(2):122-8. PubMed ID: 21430417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
    Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP
    Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of gamma-glutamyl transferase with cardiovascular risk: a prognostic outlook.
    Fink R; Mortlock S; Pearce R; Raamkoleea P; Underhill J
    Arch Med Res; 2010 Apr; 41(3):232; author reply 233. PubMed ID: 20682183
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome.
    Simão AN; Dichi JB; Barbosa DS; Cecchini R; Dichi I
    Nutrition; 2008; 24(7-8):675-81. PubMed ID: 18499396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
    Conigrave KM; Degenhardt LJ; Whitfield JB; Saunders JB; Helander A; Tabakoff B;
    Alcohol Clin Exp Res; 2002 Mar; 26(3):332-9. PubMed ID: 11923585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum gamma-glutamyl transferase (GGT) levels and inflammatory activity in patients with non-dipper hypertension.
    Ermis N; Yagmur J; Acikgoz N; Cansel M; Cuglan B; Pekdemir H; Ozdemir R
    Clin Exp Hypertens; 2012; 34(5):311-5. PubMed ID: 21797800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum gamma-glutamyltransferase: new insights about an old enzyme.
    Lee DH; Jacobs DR
    J Epidemiol Community Health; 2009 Nov; 63(11):884-6. PubMed ID: 19825792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults.
    Kang YH; Min HK; Son SM; Kim IJ; Kim YK
    Diabetes Res Clin Pract; 2007 Aug; 77(2):306-13. PubMed ID: 17353063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis.
    Koenig W
    Ann Med; 2009; 41(5):332-43. PubMed ID: 19291518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein: a novel marker of cardiovascular risk.
    Shah SH; Newby LK
    Cardiol Rev; 2003; 11(4):169-79. PubMed ID: 12852794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. gamma-Glutamyltransferase, obesity, physical activity, and the metabolic syndrome in indigenous Australian adults.
    Li M; Campbell S; McDermott R
    Obesity (Silver Spring); 2009 Apr; 17(4):809-13. PubMed ID: 19148121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcohol consumption and its relation to risk factors for cardiovascular disease in the north-west of Russia: the Arkhangelsk study.
    Nilssen O; Averina M; Brenn T; Brox J; Kalinin A; Archipovski V
    Int J Epidemiol; 2005 Aug; 34(4):781-8. PubMed ID: 15833789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is serum gamma glutamyltransferase a marker of oxidative stress?
    Lee DH; Blomhoff R; Jacobs DR
    Free Radic Res; 2004 Jun; 38(6):535-9. PubMed ID: 15346644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men.
    Ryu S; Chang Y; Woo HY; Yoo SH; Choi NK; Lee WY; Kim I; Song J
    Metabolism; 2010 May; 59(5):683-9. PubMed ID: 19922966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum gamma-glutamyltransferase activity is increased in patients with calcific aortic valve stenosis.
    Bozbas H; Yildirir A; Demir O; Cakmak A; Karacaglar E; Yilmaz M; Eroglu S; Pirat B; Ozin B; Muderrisoglu H
    J Heart Valve Dis; 2008 Jul; 17(4):371-5. PubMed ID: 18751465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between serum gamma-glutamyltransferase and C-reactive protein.
    Lee DH; Jacobs DR
    Atherosclerosis; 2005 Feb; 178(2):327-30. PubMed ID: 15694941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.